Friday 6 November 2026
Export MCK’s income statement to Excel — free account
McKesson Corporation
MCK Healthcare Medical Distribution
McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025.
- Revenue
- +7.57%
- EPS
- +17.0%
- Free cash flow
- +32.5%
- Total debt
- +7.08%
Quarter to September 2026, against a year earlier
1,061.69
10.31
−0.96%
Follow MCK
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
7 | 7 | 7 | 7 |
| (240.78%) | (274.39%) | (168.45%) | (190.51%) | ||
| 5.59% | 6.05% | 5.41% | 5.33% | ||
ROIC |
45.30% | 66.20% | 70.49% | 114.15% | |
Return on Tangible Assets |
(74.83%) | (66.70%) | (94.97%) | (93.14%) | |
Average Days of Receivables |
25.88 | 25.32 | 26.92 | 26.85 | |
Free Cash Flow per Share |
78.28 | 43.77 | 51.77 | 59.05 | |
Free Cash Flow |
9,644.00 | 5,410.00 | 6,145.00 | 6,868.00 | |
Capital Expenditures |
(838.00) | (745.00) | (708.00) | (635.00) | |
| Other line items | |||||
Cash ROIC |
70.30% | 39.16% | 38.20% | 41.08% | |
Accounts Receivable Turnover |
14.73 | 15.05 | 14.06 | 14.17 | |
Accounts Payable Turnover |
6.95 | 6.75 | 6.51 | 6.27 | |
Inventory Turnover |
15.08 | 16.48 | 15.43 | 14.85 | |
Average Days of Payables |
57.71 | 56.29 | 58.74 | 61.31 | |
Days of Inventory on Hand |
25.74 | 22.72 | 24.20 | 25.53 | |
Tax Rate |
(0.19) | (0.18) | (0.18) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.08% | 2.01% | 1.99% | 2.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
24.47 | 25.15 | 23.62 | 21.87 | |
Operating CF/Net income |
2.42 | 1.29 | 1.49 | 1.60 | |
Depreciation/Fixed assets |
0.26 | 0.27 | 0.29 | 0.29 | |
Capex/Depreciation |
(1.23) | (1.02) | (0.92) | (0.82) | |
Revenue per Share |
3,230.18 | 3,264.00 | 3,462.37 | 3,600.95 | |
Operating CF per Share |
85.08 | 49.80 | 57.73 | 64.51 | |
Capex per Share |
(6.80) | (6.03) | (5.96) | (5.46) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 4 Nov 2026